Spero Therapeutics, Inc.

US$1.03As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:SPROHealthcare
Country USA
PE (Fwd) •••
TSR 9Y CAGR (23.98%)
Div yield —
ROE 19.17%
Biotechnology
Beta (5Y) 1.56
PE TTM 8.061
TSR TTM (57.61%)
Mkt cap US$59.98M
ROIC 32.09%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.09
5.58%
81.51%
Hold 6|1|10|0|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
9.35%
12.60%
18.76%
15.60%
Revenue$M
3.564
3.558
3.688
3.742
0.17%
0.13%
3.76%
2.24%
Peers (US$59.98M)
Cap (US$)
PE
61.70M
0.569x
59.76M
—
59.75M
139.8x
Capital
TTM
5Y
10Y
Leveragex
0.965
0.505
0.503
EBIT/Intx
0.413
0.306
0.297
Own earn%
663.55
(118.06)
(101.62)
Sh yield%
43.56
48.15
48.74
Owners
Insiders/Inst%
7.67
80.02
Short interest%
3.16
SBC / revenue%
4.75
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
0–5
$1 testx
1.5
Incr. ROIC%
5